Oct 29, 2008 | 4
Cholesterol-lowering statin drugs reduce levels of a blood marker for prostate cancer, but it's not clear they actually lower the risk of developing the disease.
Scientists from Duke University report in the Journal of the National Cancer Institute that levels of prostate-specific antigen (PSA), a protein, dropped by an average of 4.1 percent over 16 years in 1,214 men taking statins. But they didn’t explore whether the meds actually reduced the incidence of prostate cancer.
Previous research has produced conflicting results: one 2005 study by the Veterans Administration suggested that statins lowered risk of the disease, but three analyses of their use for heart disease between 2005 and 2007 didn't show any link.
Deadline: Dec 11 2013
Reward: $52,000 USD
Platform technologies – tools, techniques, and instruments that enable entirely novel approaches for scientific investigation across a b
Deadline: Jan 27 2014
Reward: $15,000 USD
The Dow Chemical Company is the leading producer of polyalkylene glycols (PAGs) used in synthetic fluids and lubricants where petroleum,
Give a 1 year subscription as low as $14.99X